Ligand Pharmaceuticals
LGND | NASDAQ
$292.19
+$2.12 (+0.73%)
Sep 22, 2026, 1:01 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 63.69M | 51.72M | 59.67M | 115.46M | 47.63M | 45.33M | 42.81M | 51.81M | 41.53M | 30.98M | 28.1M | 32.87M | 26.37M | 43.98M | 27.05M | 59.22M | 50.13M | 36.52M | 72.47M | 64.84M | 84.68M | 55.15M |
Cost of Revenue | n/a | 2.08M | -25.99M | 24.82M | 2.91M | 4.85M | 2.84M | 12.5M | -15.33M | 11.07M | 1.66M | 3.49M | 1.67M | 3.72M | 21.61M | 14.15M | 12.36M | 4.7M | 11.98M | 11.45M | 30.59M | 8.15M |
Gross Profit | 63.69M | 49.65M | 85.65M | 90.64M | 44.72M | 40.48M | 39.98M | 39.32M | 56.86M | 19.91M | 26.44M | 29.38M | 24.7M | 40.26M | 5.43M | 45.07M | 37.77M | 31.82M | 60.49M | 53.39M | 54.08M | 47M |
Operating Income | 8.59M | 17.37M | 20.04M | 54.93M | 8.44M | -36.22M | -9.64M | 3.14M | -19.1M | 2.99M | -3.36M | 3.08M | -1.98M | 14.21M | 12.18M | 12.34M | 8.66M | 2.13M | 12.73M | 15.71M | 45.74M | 4.72M |
Interest Income | n/a | 6.66M | 6.39M | 2.96M | 1.62M | 1.77M | 1.93M | 1.35M | 2.76M | 2.02M | 1.69M | 2.26M | 2.32M | 1.44M | 1.02M | 591K | 298K | 134K | 188K | 169K | 233K | 296K |
Pretax Income | 64.3M | -24.26M | 56.78M | 141.14M | 11.22M | -50.18M | -39.2M | -6.34M | -65.39M | 113.45M | 17.1M | -12.14M | 3.17M | 55.54M | 55.93M | 12.35M | 8.66M | -9.14M | -7.03M | 15.26M | 33.3M | 5.76M |
Net Income | 48.51M | -13.35M | 44.78M | 117.27M | 4.85M | -42.45M | -31.09M | -7.17M | -51.91M | 86.14M | 18.19M | -10.27M | 2.29M | 41.95M | -17.49M | 404K | -895K | -15.39M | -5.42M | 13.72M | 30.73M | 18.11M |
Selling & General & Admin | 29.12M | 20.84M | 25.03M | 28.45M | 20.18M | 18.8M | 25.61M | 24.48M | 17.62M | 10.95M | 15.99M | 14.66M | 11.29M | 10.86M | 19.85M | 14.92M | 12.09M | 11.93M | 17.74M | 12.72M | 14.71M | 12.62M |
Research & Development | 14.67M | 2.15M | 3.51M | 21.02M | 6.57M | 50.09M | 4.43M | 5.68M | 5.35M | 5.97M | 5.49M | 5.53M | 6.85M | 6.66M | -25.38M | 9.24M | 8.47M | 9.18M | 18.24M | 16.94M | 15.95M | 17.88M |
Other Expenses | 11.31M | 9.3M | 37.08M | -13.76M | 9.53M | 7.81M | 19.58M | 6.02M | 52.98M | n/a | 8.32M | 6.12M | 8.54M | 8.54M | -1.22M | 8.57M | 8.55M | 8.58M | 11.78M | 8.03M | -22.32M | 11.79M |
Operating Expenses | 55.1M | 32.28M | 65.61M | 35.71M | 36.28M | 76.7M | 49.61M | 36.17M | 75.96M | 16.92M | 29.8M | 26.31M | 26.68M | 26.06M | -6.75M | 32.73M | 29.1M | 29.68M | 47.76M | 37.68M | 8.34M | 42.28M |
Interest Expense | n/a | 1.75M | 1.79M | n/a | 1.15M | 867K | 883K | 741K | 1.27M | 141K | 131K | 1K | 284K | 240K | 240K | 332K | 438K | 789K | 4.47M | 4.44M | 4.88M | 5.83M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 55.1M | 34.35M | 39.63M | 60.53M | 39.18M | 81.55M | 52.45M | 48.67M | 60.63M | 27.99M | 31.46M | 29.79M | 28.35M | 29.77M | 14.87M | 46.88M | 41.46M | 34.38M | 59.74M | 49.13M | 38.94M | 50.44M |
Income Tax Expense | 15.8M | -10.91M | 12M | 23.86M | 6.38M | -7.73M | -8.11M | 833K | -13.48M | 27.31M | -1.09M | -1.87M | 881K | 11.92M | 45.27M | 2.71M | -3.94M | 3.79M | -1.61M | 1.54M | 2.58M | -12.34M |
Shares Outstanding (Basic) | 20.06M | 19.88M | 19.73M | 19.37M | 19.33M | 19.19M | 18.97M | 18.42M | 18.03M | 17.73M | 17.47M | 17.38M | 17.28M | 17.06M | 16.89M | 16.89M | 16.87M | 16.82M | 16.73M | 16.69M | 16.66M | 16.44M |
Shares Outstanding (Diluted) | 21.84M | 19.88M | 21.14M | 20.17M | 19.93M | 19.19M | 18.97M | 18.42M | 18.03M | 18.12M | 17.68M | 17.38M | 17.73M | 17.97M | 16.89M | 17.13M | 16.87M | 16.82M | 16.73M | 17.14M | 17.17M | 17.25M |
EPS (Basic) | 2.42 | -0.67 | 2.27 | 5.99 | 0.25 | -2.21 | -1.64 | -0.39 | -2.88 | 4.86 | 1.04 | -0.74 | 0.13 | 2.46 | -1.04 | 0.02 | -0.05 | -0.91 | -0.30 | 0.82 | 1.84 | 1.10 |
EPS (Diluted) | 2.22 | -0.67 | 2.12 | 5.68 | 0.24 | -2.21 | -1.64 | -0.39 | -2.88 | 4.75 | 1.03 | -0.74 | 0.13 | 2.33 | -1.04 | 0.02 | -0.05 | -0.91 | -0.30 | 0.80 | 1.79 | 1.05 |
EBITDA | 72.4M | -14.3M | 66.4M | 149.23M | 20.9M | -40.54M | -29.69M | 3.4M | -55.27M | 122.35M | 26.15M | -3.53M | 12.95M | 65.34M | 67.3M | 26.19M | 22.19M | 5.29M | 10.39M | 24.52M | 23.93M | 24.69M |
EBIT | 64.3M | -22.51M | 56.78M | 141.14M | 12.38M | -49.31M | -38.32M | -5.6M | -64.12M | 113.59M | 17.23M | -12.14M | 3.46M | 55.78M | 56.17M | 12.69M | 9.1M | -8.36M | -2.55M | 11.91M | 11.64M | 11.6M |
Depreciation & Amortization | 8.1M | 8.22M | 9.62M | 8.1M | 8.52M | 8.77M | 8.63M | 8.99M | 8.85M | 8.77M | 8.92M | 8.61M | 9.5M | 9.57M | 11.13M | 13.51M | 13.09M | 13.64M | 12.95M | 12.61M | 12.29M | 13.09M |
Add to Watchlist
Select watchlists to add or remove LGND